Amylyx Drug Slashes Sugar Spikes Post-Weight Loss Surgery

Amylyx reports strong Phase 2b trial data for avexitide, showing 64% fewer hypoglycemic events in patients with post-bariatric hypoglycemia.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *